ScholarIQanswers from OpenAlex & ORCID
Ludwig Kappos
ResearcherPublications, citations & collaboration network
Ludwig Kappos is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ludwig Kappos have?
ScholarIQindexed works
Ludwig Kappos has 1,338 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ludwig Kappos have?
ScholarIQcitation count
Ludwig Kappos has 104,991 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ludwig Kappos?
ScholarIQh-index
Ludwig Kappos has an h-index of 139 in OpenAlex.
What is the i10-index of Ludwig Kappos?
ScholarIQi10-index
Ludwig Kappos has an i10-index of 632 in OpenAlex.
What is the ORCID of Ludwig Kappos?
ScholarIQorcid
The ORCID for Ludwig Kappos is on the source record.
What is the OpenAlex record for Ludwig Kappos?
ScholarIQopenalex
The OpenAlex for Ludwig Kappos is on the source record.
What are the most-cited papers on Ludwig Kappos?
ScholarIQmost cited works
Defining the clinical course of multiple sclerosis
Fred Lublin, Stephen C. Reingold, Jeffrey A. Cohen, Gary Cutter, Per Soelberg Sørensen, Alan J. Thompson, Jerry S. Wolinsky, Laura J. Balcer, Brenda Banwell, Frederik Barkhof, Bruce F. Bebo, Peter A. Calabresi, Michel Clanet, Giancarlo Comi, Robert J. Fox, Mark S. Freedman, Andrew Goodman, Matilde Inglese, Ludwig Kappos, Bernd C. Kieseier, John A. Lincoln, Catherine Lubetzki, Aaron E. Miller, Xavier Montalbán, Paul O’Connor, John Petkau, Carlo Pozzilli, Richard A. Rudick, Maria Pia Sormani, Olaf Stüve, Emmanuelle Waubant, Chris H. Polman
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
Xavier Montalbán, Ralf Gold, Alan J. Thompson, Susana Otero-Romero, Maria Pia Amato, Dhia Chandraratna, M. Clanet, Gıancarlo Comı, Tobias Derfuß, Franz Fazekas, Hans Hartung, Eva Havrdová, Bernhard Hemmer, Ludwig Kappos, Roland Liblau, Catherine Lubetzki, Elena Marcus, David H. Miller, Tomas Olsson, Steve Pilling, Krzysztof Selmaj, Aksel Sıva, Per Soelberg Sørensen, Maria Pia Sormani, Christoph Thalheim, Heinz Wiendl, Frauke Zipp
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
Fred Lublin, David H. Miller, Mark S. Freedman, Bruce Cree, Jerry S. Wolinsky, Howard L. Weiner, Catherine Lubetzki, Hans‐Peter Hartung, Xavier Montalbán, Bernard M.J. Uitdehaag, Martin Merschhemke, Bingbing Li, Norman Putzki, Fonda Liu, Dieter A. Häring, Ludwig Kappos
Genome-wide Association Study in a High-Risk Isolate for Multiple Sclerosis Reveals Associated Variants in STAT3 Gene
Eveliina Jakkula, Virpi Leppä, Anna-Maija Sulonen, Teppo Varilo, Suvi Kallio, Anu Kemppinen, Shaun Purcell, Keijo Koivisto, Pentti J. Tienari, Marja‐Liisa Sumelahti, Irina Elovaara, Tuula Pirttilä, Mauri Reunanen, Arpo Aromaa, Annette Oturai, Helle Bach Søndergaard, Hanne F. Harbo, Inger‐Lise Mero, Stacey B. Gabriel, Daniel B. Mirel, Stephen L. Hauser, Ludwig Kappos, Chris H. Polman, Philip L. De Jager, David A. Hafler, Mark J. Daly, Aarno Palotie, Janna Saarela, Leena Peltonen
Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
Sefika Özcelik, Graham Fraser, Perrine Castets, Véronique Schaeffer, Zhiva Skachokova, Karin Breu, Florence Clavaguera, Michael Sinnreich, Ludwig Kappos, Michel Goedert, Markus Tolnay, David T. Winkler